Campbell & CO Investment Adviser LLC Pulmonx Corp Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
$8.71 - $14.65 $636,378 - $1.07 Million
-73,063 Reduced 85.28%
12,609 $116,000
Q4 2023

Feb 13, 2024
BUY
$7.89 - $13.14 $317,903 - $529,436
40,292 Added 88.79%
85,672 $1.09 Million
Q3 2023

Nov 08, 2023
BUY
$9.88 - $14.0 $257,067 - $364,266
26,019 Added 134.39%
45,380 $468,000
Q2 2023

Aug 11, 2023
BUY
$10.78 - $13.65 $208,711 - $264,277
19,361 New
19,361 $253,000

Others Institutions Holding LUNG

# of Institutions
123
Shares Held
31M
Call Options Held
300
Put Options Held
204K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email